IBHC advisors LLC provides executive advisory services and board of directors service for medical technology companies to support their growth and value creation. It serves Private Equity firms and medical technology companies seeking accelerated growth.

Non compensated volunteer position. Led the formation and the development of the foundation. Provides strategic leadership to the Foundation, whose Mission is to improve the lives of those with nerve problems through advancing and promoting excellence in nerve care. Lead the Board of Directors

Member of the Executive Team reporting to the CEO. Orchestrated the development of the strategic plan while driving the development and the prioritization of the portfolio of strategic initiatives supporting Axogen strategic objectives (growth, profitability, competitive position) including assessment, diligence and negotiation of inorganic acquisitions. Orchestrated the team preparation for Board of Directors Meetings. Led the international and business analytic teams

Clinical Innovations is one of the largest medical device companies exclusively focused on labor and delivery and neonatal intensive care. Served on the Board of Directors under EQT Partners ownership, until Clinical Innovations acquisition by Laborie in February 2020.

IBHC advisors LLC provides executive advisory services for medical technology companies to support their growth and value creation, at any time of their lifecycle. We are serving Private Equity firms, start-up businesses, small to medium-size medical technology companies seeking accelerated growth and foreign companies preparing to enter the US market.Engagements include:- Investment / new business development support including sector strategy, target identification, due diligence, commercialization hypothesis, integration and value creation plan- Board representation- Strategic plan development and evaluation of growth strategies- Global go-to-market strategies and prioritization of geographies- Commercialization and marketing processes optimization- US market entry strategy: market assessment, positioning, go-to-market entry options

New position created by Cardinal Health in 2010, accountable for driving the growth of the preferred products portfolio across all its Medical segment distribution channels: portfolio strategy and prioritization, new product development, development and execution of customer and supplier programs, product data strategy development and management.Drove process changes that positioned the medical segment for accelerated Cardinal Health branded products growth

Management board member of the largest division of CR Bard in charge of marketing and new business development including strategy development and strategic planning, merger and acquisition, new product pipeline development, product launches and operational marketing management.Revitalized a mature business and achieved double digit global growth

New position dedicated to the creation and development of a new growth platform for Ethicon and the brand augmentation of a major product line: Strategy development and pipeline development, Geographic prioritization, Management of a global cross functional worldwide specialty team, KOL managementCreated the growth plan for a new business and initiated execution

Held 4 positions of increasing responsibilities in Europe and US. Member of the Ethicon Products Management Board in last position. Assessment, negotiation, execution and integration of transactions, global strategic assessments, cross functional team management for transaction assessment and execution, process development.Drove the acquisition of new technology platforms that transformed the standard of care and enabled product leadership positions

Held 3 positions of increasing responsibilities in France, US and Europe.Product launch of the STERRAD Sterilization Technology in France, 1st country to launch the system globally, upstream marketing efforts in US for the launch of next generation systems, elaboration and execution of European strategic planLaunched a new transformational technology that created a new growth platform for Johnson & Johnson

Lead the management of all medical supply, drug, OR equipment, infection control in a 200 beds private hospital specialized in neuro-surgery and diseases of the neurological system: Surgeon and MD collaboration, negotiation, new device evaluation, hygiene protocols and sterilization, inventory management and optimizationCreated discipline on drug and devices purchasing and standardized care practices